课题基金 / 基金详情

CAREER: Metabolic Determinants of Programmed Cell Death in Hepatic Lipotoxicity

CAREER: Metabolic Determinants of Programmed Cell Death in Hepatic Lipotoxicity
职业:肝脂毒性中程序性细胞死亡的代谢决定因素
批准号:
0955251
负责人:
Jamey Young
金额:
$40.0万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2016-06-30

项目摘要

项目成果

Jamey Young的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
0955251YoungThe overall objective of the current application is to elucidate the mechanism by which metabolic changes activate apoptotic signaling in hepatic cells exposed to elevated saturated fatty acids (SFAs).The central hypothesis is that endoplasmic reticulum (ER) stress induced by SFAs leads to altered coupling between central carbon pathways, which subsequently triggers mitochondrial accumulation of reactive oxygen species (ROS) resulting in apoptosis. The rationale for the proposed research is that, once it is known how metabolic pathway fluxes impact lipid-induced apoptosis, these pathways can be modulated by therapeutic interventions that target the underlying metabolic factors causing lipotoxicity. The plan is to test the central hypothesis by pursuing the following specific aims. First, to determine the mechanism by which SFAs induce ROS accumulation in hepatic cells. Second, to identify the lipid intermediate responsible for inducing ER stress in SFA-treated hepatic cells. These aims will be accomplished using a systems approach that focuses on integrated metabolic pathways versus individual reactions and where the concept of the metabolic network is of central importance. The approach involves both GC-MS metabolic profiling to track the relative concentrations and isotopic labeling patterns of many different intracellular metabolites simultaneously, as well as metabolic flux analysis (MFA) to reconstruct comprehensive flux maps that represent the dynamic flow of material throughout the network. By subjecting hepatic cells to a variety of treatments aimed at perturbing lipid and central carbon metabolism, they will dissect the pathways involved in SFA-induced lipotoxicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FMRG: Bio: Enabling Technologies for Biomanufacturing Extracellular Vesicle-Based Therapeutics
  • 批准号:
    2328276
  • 项目类别:
    Standard Grant
  • 资助金额:
    $300.0万
  • 财政年份:
    2024
  • 负责人:
    Jamey Young
  • 依托单位:
Collaborative Research: GOALI: Dynamic regulation of CHO metabolism to optimize biomanufacturing yields and quality
  • 批准号:
    2035085
  • 项目类别:
    Standard Grant
  • 资助金额:
    $32.6万
  • 财政年份:
    2021
  • 负责人:
    Jamey Young
  • 依托单位:
FMSG: Enabling Technologies for Biomanufacturing EV-Based Therapeutics
  • 批准号:
    2036809
  • 项目类别:
    Standard Grant
  • 资助金额:
    $50.0万
  • 财政年份:
    2020
  • 负责人:
    Jamey Young
  • 依托单位:
Collaborative Research: GOALI: Metabolic Engineering of Next Generation CHO Hosts for Monoclonal Antibody Production
  • 批准号:
    1604426
  • 项目类别:
    Standard Grant
  • 资助金额:
    $30.0万
  • 财政年份:
    2016
  • 负责人:
    Jamey Young
  • 依托单位:
国内基金
海外基金
丝氨酸/甘氨酸/一碳代谢网络(SGOC metabolic network)调控炎症性巨噬细胞活化及脓毒症病理发生的机制研究
  • 批准号:
    81930042
  • 项目类别:
    重点项目
  • 资助金额:
    305.0万元
  • 批准年份:
    2019
  • 负责人:
    王迪
  • 依托单位: